Establishment of Diagnosis and Classification System for Lung Interstitial and Airway Diseases (LIAD)

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-80
SponsorXiangya Hospital of Central South University

About this trial

This study focuses on both hospitalized and outpatient populations. Through a multicenter, retrospective study, it aims to comprehensively characterize:The comorbidity of interstitial lung diseases (ILD) and airway diseases;The comorbidity of ILD with other intrapulmonary diseases;The comorbidity of airway diseases with other intrapulmonary diseases;The comorbidity of ILD and airway diseases with extrapulmonary diseases.Based on these findings, the study seeks to propose classification and diagnostic criteria for ILD and airway disease comorbidities.Additionally, a multicenter, prospective, disease-specific cohort study will be conducted to observe the prognosis of patients with ILD and/or airway diseases, identify prognostic factors, and grade the severity of comorbid conditions based on these factors.Finally, the study will analyze the current state of interventions and the medical costs associated with ILD and airway disease comorbidities through a cost-effectiveness analysis, aiming to propose new strategies for integrated disease management.

Eligibility criteria

Qualifiers

age between 40-80 years old;

inpatients with an admission diagnosis of COPD, Idiopathic pulmonary fibrosis, nonspecific interstitial pneumonia, patients with the following diagnoses were screened by chest CT (slice thickness ≤1.5 mm) during hospitalization and by in-hospital or prior pulmonary function;

the inpatients could complete pulmonary function and chest CT examination within 1 month after discharge;

among outpatients, patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, nonspecific interstitial pneumonia, COPD with pulmonary interstitial abnormalities, idiopathic pulmonary fibrosis with airway lesions, nonspecific interstitial pneumonia with airway lesions, pulmonary fibrosis with emphysema syndrome were diagnosed through chest CT (layer thickness ≤1.5mm) and lung function;

Disqualifiers

expected survival less than 12 months;

planned lung transplantation or pneumonectomy within 12 months;

pregnant or lactating women.

Trial design

Treatments tested in this trial

  • no intervention

Treatment groups

900 Participants
are divided into 7 treatment groups

7

Treatment groups

See each treatment group below.

Locations

This trial has no locations

Sponsors and collaborators

Xiangya Hospital of Central South University

Lead sponsor

Beijing Hospital

Collaborator

Henan Provincial People's Hospital

Collaborator

Zhejiang University

Collaborator

Zhongshan Hospital (Xiamen), Fudan University

Collaborator

The Affiliated Hospital of Qingdao University

Collaborator

The Affiliated Hospital Of Guizhou Medical University

Collaborator

China-Japan Friendship Hospital

Collaborator

First Hospital of China Medical University

Collaborator